Ryan Zeidan

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Ryan Zeidan

The proxy statement of Tempest Therapeutics, Inc. reports total compensation of $849,145 for Ryan Zeidan in fiscal 2019, including a base salary of $320,625.

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Explain Ryan Zeidan's disclosed executive compensation over time and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Tempest Therapeutics, Inc. (TPST)
Proxy statement

Start not stated–2020-04-24

Last confirmed by a filing; no departure on record

Company network

Recorded roles and call appearances connecting this person to public companies.

Tempest Therapeutics, Inc.

TPST

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2019	Tempest Therapeutics, Inc. (TPST)	Chief Development Officer	$320,625	$40,000	—	$337,460	$106,566	$44,494	$849,145

Recent activity

No call appearances or filed executive changes recorded yet.